报价延迟最少15分钟:2026/04/21 20:02 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
6.04 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-14.80/-4.06
|
|
企业价值
11.27M
|
| 资产负债 |
|
每股账面净值
7.27
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively havethe potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others. |
